BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16164564)

  • 1. A genome-wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species.
    Panina EM; Mattoo S; Griffith N; Kozak NA; Yuk MH; Miller JF
    Mol Microbiol; 2005 Oct; 58(1):267-79. PubMed ID: 16164564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chaperone binding domain of SopE inhibits transport via flagellar and SPI-1 TTSS in the absence of InvB.
    Ehrbar K; Winnen B; Hardt WD
    Mol Microbiol; 2006 Jan; 59(1):248-64. PubMed ID: 16359332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved features of type III secretion.
    Tampakaki AP; Fadouloglou VE; Gazi AD; Panopoulos NJ; Kokkinidis M
    Cell Microbiol; 2004 Sep; 6(9):805-16. PubMed ID: 15272862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.
    Hegerle N; Rayat L; Dore G; Zidane N; Bedouelle H; Guiso N
    Microbes Infect; 2013 May; 15(5):399-408. PubMed ID: 23470234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III secretion chaperones of Pseudomonas syringae protect effectors from Lon-associated degradation.
    Losada LC; Hutcheson SW
    Mol Microbiol; 2005 Feb; 55(3):941-53. PubMed ID: 15661015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of type III secretion in Bordetella.
    Mattoo S; Yuk MH; Huang LL; Miller JF
    Mol Microbiol; 2004 May; 52(4):1201-14. PubMed ID: 15130135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and membrane-targeting of a Bordetella pertussis effector N-terminal domain.
    Yahalom A; Davidov G; Kolusheva S; Shaked H; Barber-Zucker S; Zarivach R; Chill JH
    Biochim Biophys Acta Biomembr; 2019 Dec; 1861(12):183054. PubMed ID: 31487494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.
    Parkhill J; Sebaihia M; Preston A; Murphy LD; Thomson N; Harris DE; Holden MT; Churcher CM; Bentley SD; Mungall KL; Cerdeño-Tárraga AM; Temple L; James K; Harris B; Quail MA; Achtman M; Atkin R; Baker S; Basham D; Bason N; Cherevach I; Chillingworth T; Collins M; Cronin A; Davis P; Doggett J; Feltwell T; Goble A; Hamlin N; Hauser H; Holroyd S; Jagels K; Leather S; Moule S; Norberczak H; O'Neil S; Ormond D; Price C; Rabbinowitsch E; Rutter S; Sanders M; Saunders D; Seeger K; Sharp S; Simmonds M; Skelton J; Squares R; Squares S; Stevens K; Unwin L; Whitehead S; Barrell BG; Maskell DJ
    Nat Genet; 2003 Sep; 35(1):32-40. PubMed ID: 12910271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bpel locus encodes type III secretion machinery in Bordetella pertussis.
    Kerr JR; Rigg GP; Matthews RC; Burnie JP
    Microb Pathog; 1999 Dec; 27(6):349-67. PubMed ID: 10588908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PsrA is a positive transcriptional regulator of the type III secretion system in Pseudomonas aeruginosa.
    Shen DK; Filopon D; Kuhn L; Polack B; Toussaint B
    Infect Immun; 2006 Feb; 74(2):1121-9. PubMed ID: 16428760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BtcA, A class IA type III chaperone, interacts with the BteA N-terminal domain through a globular/non-globular mechanism.
    Guttman C; Davidov G; Yahalom A; Shaked H; Kolusheva S; Bitton R; Barber-Zucker S; Chill JH; Zarivach R
    PLoS One; 2013; 8(12):e81557. PubMed ID: 24312558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III secretion of the Salmonella effector protein SopE is mediated via an N-terminal amino acid signal and not an mRNA sequence.
    Karavolos MH; Roe AJ; Wilson M; Henderson J; Lee JJ; Gally DL; Khan CM
    J Bacteriol; 2005 Mar; 187(5):1559-67. PubMed ID: 15716426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics-enabled identification of the HrpL regulon and type III secretion system effector proteins of Pseudomonas syringae pv. phaseolicola 1448A.
    Vencato M; Tian F; Alfano JR; Buell CR; Cartinhour S; DeClerck GA; Guttman DS; Stavrinides J; Joardar V; Lindeberg M; Bronstein PA; Mansfield JW; Myers CR; Collmer A; Schneider DJ
    Mol Plant Microbe Interact; 2006 Nov; 19(11):1193-206. PubMed ID: 17073302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bordetella type III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts.
    French CT; Panina EM; Yeh SH; Griffith N; Arambula DG; Miller JF
    Cell Microbiol; 2009 Dec; 11(12):1735-49. PubMed ID: 19650828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Btc22 chaperone is required for secretion and stability of the type III secreted protein Bsp22 in Bordetella bronchiseptica.
    Kurushima J; Kuwae A; Abe A
    FEMS Microbiol Lett; 2012 Jun; 331(2):144-51. PubMed ID: 22458424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic diversity analysis of isolates belonging to Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica species].
    Mosiej E; Gzyl A; Slusarczyk J
    Med Dosw Mikrobiol; 2006; 58(2):143-53. PubMed ID: 17133908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
    Fennelly NK; Sisti F; Higgins SC; Ross PJ; van der Heide H; Mooi FR; Boyd A; Mills KH
    Infect Immun; 2008 Mar; 76(3):1257-66. PubMed ID: 18195025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for pore formation on the host plasma membrane.
    Nogawa H; Kuwae A; Matsuzawa T; Abe A
    J Bacteriol; 2004 Jun; 186(12):3806-13. PubMed ID: 15175294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of the effector protein BteA was attenuated in Bordetella pertussis by insertion of an alanine residue.
    Bayram J; Malcova I; Sinkovec L; Holubova J; Streparola G; Jurnecka D; Kucera J; Sedlacek R; Sebo P; Kamanova J
    PLoS Pathog; 2020 Aug; 16(8):e1008512. PubMed ID: 32776984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a type III secretion-associated chaperone in the type III secretion system 1 of Vibrio parahaemolyticus.
    Akeda Y; Okayama K; Kimura T; Dryselius R; Kodama T; Oishi K; Iida T; Honda T
    FEMS Microbiol Lett; 2009 Jul; 296(1):18-25. PubMed ID: 19459967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.